TB
Thomas Bridge
Senior Scientist at Keltic Pharma Therapeutics
View Thomas's Contact Info for Free. Sign Up and Get 50 Free Contacts Per Month.Get Started for Free
Work Experience
Senior Scientist
Mar 2022 - Present · 2 years and 10 months
University of East Anglia
Postdoctoral Researcher
Jan 2020 - Dec 2021 · 1 years and 11 months
Company Details
11-50 Employees
In 2019 Prof Andrew Tobin published validation of PfCLK3 as a target with breakthrough potential in the treatment of malaria. Successful drug development would provide a single medicine that is curative, transmission blocking and prophylactic.
Website
Year Founded
2020
Social Media
Linkedin
Industry
Pharmaceutical Manufacturing
HQ Location
27 Pembroke Street Upper
Dublin, IE
Keywords
--
Contact Details
- Email AddressT**@keltic-pharma.comReveal Email
- Phone Number(xxx)xxx-xxxxReveal Phone
Find verified contacts of Thomas Bridge in seconds from 700M people profiles. Start now!
Continue with GoogleNo Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.